Trial of Art Therapy During Cognitive Processing Therapy for PTSD

Post-traumatic Stress Disorder Clinical Trial

— Art_Tx_PTSD  

Official title:

Randomized, Controlled Trial of Art Therapy During Cognitive Processing Therapy for PTSD

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02610049
• Other study ID #: 13-04
• Status: Terminated
• Phase: N/A
• First received: November 17, 2015
• Last updated: August 8, 2017
• Start date: November 2013
• Est. completion date: February 13, 2017

Study information

• Verified date: August 2017
• Source: Hampton VA Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a randomized, controlled trial of adjunctive art therapy during cognitive processing therapy for PTSD.

Description:

The objective of this study is to examine the effects of art therapy with combat veterans who have PTSD and to measure if it reduces symptoms more than verbal Cognitive Processing Therapy (CPT) alone. This study will incorporate art processes and materials into an already established protocol of CPT in order to create a sense of safety for veterans in beginning therapy, and access the nonverbal parts of the trauma in order to process it. Art-making will be used to help veterans address trauma and integrate who they were before the trauma with who they are currently. It will assist in addressing the grief and loss caused by combat, and will be used as veterans begin building a worldview and self-concept that are not filled with trauma and war. It is hypothesized that the veterans who receive art therapy with CPT will show a significantly greater decrease in PTSD symptoms than those who receive only CPT.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 31
• Est. completion date: February 13, 2017
• Est. primary completion date: February 3, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• PCL-M initial score >= 50;

• Both genders,

• All ethnicities,

• Veterans in treatment for PTSD,

Exclusion Criteria:

• No active substance use disorder,

• No active suicidal or homicidal ideation,

• No psychosis

Related Conditions & MeSH terms

• Disease
• Post-traumatic Stress Disorder
• Stress Disorder, Post-Traumatic
• Stress Disorders, Post-Traumatic
• Stress Disorders, Traumatic

Intervention

Behavioral:
• Cognitive Processing therapy
8 sessions of standard CPT from CPT manual developed by Dr. S Resick, Monson & Chard (11/2010)
• Art + CPT
8 sessions of individual therapy of mixes techniques Art + CPT 8 sessions of standard CPT (same 8 as in control group) from manual developed by Dr.s Resick, Monson & Chard (11/2010)
• CPT + Art Therapy
Subjects to complete 8 sessions of standard Cognitive Processing Therapy from manual developed by Dr. S. Resick, Monson & Chard (1/2010) CPT + Art Therapy of mixed individual techniques

Locations

Country	Name	City	State
United States	Hampton VA Medical Center	Hampton	Virginia

Sponsors (1)

Lead Sponsor	Collaborator
Hampton VA Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	PTSD Symptoms assessed by PCL-M score	PTSD symptoms will be measured by PCL-M score	8-12 weeks
Primary	Depression Symptoms assessed by Beck Depression Inventory-II	Beck Depression Inventory-II will be used to measure depression	8-12 weeks
Secondary	Treatment Satisfaction assessed by Likert scale	Likert scale will be used to compare satisfaction with art and CPT conditions	8-12 weeks
Secondary	Treatment completion assessed by dropout rate	Compare dropout rate between experimental and control groups during treatment	8-12 weeks